Search

Your search keyword '"Scher, Jose U."' showing total 132 results

Search Constraints

Start Over You searched for: Author "Scher, Jose U." Remove constraint Author: "Scher, Jose U." Database Unpaywall Remove constraint Database: Unpaywall
132 results on '"Scher, Jose U."'

Search Results

1. Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study

2. Racial and ethnic determinants of psoriatic arthritis phenotypes and disease activity

5. Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry

6. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings

7. Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems

10. Responsiveness and minimal clinically important difference in patient‐reported outcome measures among patients with psoriatic arthritis

13. Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin

14. Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial

16. Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City

17. COVID-19 outcomes in patients with psoriasis and psoriatic arthritis: A prospective cohort study

19. Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease

20. A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation

21. Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis

23. Clinical validation of digital biomarkers and machine learning models for remote measurement of psoriasis and psoriatic arthritis

24. Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study

25. Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting

26. GRAPPA 2020 Research Award Recipients

30. Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS – CoV ‐2 Vaccination

31. 1206 Evaluation of SARS-CoV-2 IgG antibody reactivity in a multi-racial/ethnic cohort of patients with systemic lupus erythematosus

32. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures

33. Does biologic therapy impact the development of PsA among patients with psoriasis?

34. Contributors

36. New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine

37. Psoriatic arthritis

38. Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort

41. Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

42. Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease

43. The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis

44. National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments

46. Another ‘BEE’? – Brain-Eye-Ear (BEE) Disease Secondary to HbSC Disease Masquerading as Multiple Sclerosis

49. Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study

50. Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting

Catalog

Books, media, physical & digital resources